ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01712061
Brief Title: A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy

First Submitted : October 19, 2012
First Submitted that Met QC Criteria : October 19, 2012
First Posted : October 23, 2012 (Estimate)

Results First Submitted : September 22, 2015
Results First Submitted that Met QC Criteria : September 22, 2015
Results First Posted : October 21, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : September 22, 2015
Last Update Posted : October 21, 2015 (Estimate)